UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

Kilburn, Lindsay B; Khuong-Quang, Dong-Anh; Hansford, Jordan R; Landi, Daniel; van der Lugt, Jasper; Leary, Sarah ES; Driever, Pablo Hernaiz; ... Nysom, Karsten; + view all (2024) Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. [Corrigendum]. Nature Medicine 10.1038/s41591-024-02910-1. (In press). Green open access

[thumbnail of Hargrave_s41591-024-02910-1.pdf]
Preview
Text
Hargrave_s41591-024-02910-1.pdf

Download (493kB) | Preview

Abstract

Correction to: Nature Medicine https://doi.org/10.1038/s41591-023-02668-y, published online 17 November 2023.

Type: Article
Title: Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/s41591-024-02910-1
Publisher version: https://doi.org/10.1038/s41591-024-02910-1
Language: English
Additional information: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Keywords: Drug development, Paediatric cancer, Phase II trials, Randomized controlled trials, Targeted therapies
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10191064
Downloads since deposit
4Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item